Skip to main content
Trending
Corporate earningsAi infrastructureEnergy marketsElection litigationAviation safetyCrypto securityAi governanceEnterprise aiPlatform liabilityAvian influenzaClinical trialsFederal debtPresidential runoffRpg developmentSpace debrisAir defenseAutonomous vehiclesBudget crisisBug bountiesEnergy m&aForeign investmentFranchise restructuringGene therapyPandemic treatyTranslation pathwaysUn peacekeepingWeapons testingWeight-space programmingAi copyright lawArchaeological toxicology

full timeline

Large Cohort Study Links GLP-1 Medications to 30% Lower Breast Cancer Risk

A University of Pennsylvania study using AI to analyze social media posts has uncovered secondary effects of GLP-1 medications, including menstrual changes, temperature dysregulation, and bone density loss. Understanding these trade-offs allows patients to pair the drugs with targeted lifestyle interventions.

Factlen Newsroom· Updated

Follow Large Cohort Study Links GLP-1 Medications to 30% Lower Breast Cancer Risk in the Factlen app and get an alert when there is news. Get the app

From: AI Analysis of 400,000 Patients Reveals Unreported GLP-1 Side Effects and How to Mitigate Them

Share this story

Key numbers

400,000
Reddit posts analyzed by AI
3.8%
Users reporting menstrual changes
6.9%
Users reporting sulfur belches
0.5–1.0%
Bone density loss over 12-18 months

From: AI Analysis of 400,000 Patients Reveals Unreported GLP-1 Side Effects and How to Mitigate Them

Charts, maps and images

The physiological trade-offs of rapid weight loss induced by GLP-1 receptor agonists.From: AI Analysis of 400,000 Patients Reveals Unreported GLP-1 Side Effects and How to Mitigate Them ·
Frequency of unreported symptoms identified in the Nature Health AI analysis of 400,000 Reddit posts.From: AI Analysis of 400,000 Patients Reveals Unreported GLP-1 Side Effects and How to Mitigate Them ·
Data from the matched cohort showed a significant reduction in breast cancer incidence among GLP-1 users.From: Large Cohort Study Links GLP-1 Medications to 30% Lower Breast Cancer Risk ·
Absolute risk reduction observed in the Penn Medicine retrospective cohort study.From: Large Cohort Study Links GLP-1 Medications to 30% Lower Breast Cancer Risk ·
Scientists believe GLP-1 medications may inhibit tumor growth through multiple biological pathways.From: Large Cohort Study Links GLP-1 Medications to 30% Lower Breast Cancer Risk ·

Timeline